Brought to you by:
VAM: Industry-sponsored symposia
Industry-sponsored symposia at the Vascular Annual Meeting (VAM) will be presented Wednesday and Thursday evenings and at three breakfast sessions taking place Thursday morning. Industry-supported evening Satellite Symposia will be held from 6:30 to 8 p.m. Wednesday and Thursday. Wednesday’s…
Study of amputees finds referral for prosthetics to be an independent predictor of long-term survival
Prosthetic referral was an independent predictor of long-term survival among patients who had undergone lower-extremity amputation, new findings set to be published in the Journal of Vascular Surgery will reveal. A single-center retrospective study by William Shutze, MD, a vascular…
AHA publishes updated scientific statement on PAD
The American Heart Association (AHA) has released a new scientific statement on lower extremity peripheral arterial disease (PAD), focusing on contemporary epidemiology, management gaps, and future directions. The statement, authored by Michael H. Criqui, MD, a distinguished professor in the division of preventive…
Special session on diversity enters VAM agenda
Over the course of more than a year, diversity, equity and inclusion (DEI) have been brought into sharp focus by a compendium of events inside and outside of medicine. As U.S. society has reckoned with the socioeconomic and cultural consequences…
The year in COVID: VAM to feature 10 talks probing pandemic-related vascular complications
After nearly 18 months of life dominated by a worldwide pandemic—one that canceled the 2020 Vascular Annual Meeting (VAM)—VAM 2021 highlights several aspects of COVID-19 in a special session. The coronavirus session will be from 5 to 6:30 p.m. Wednesday…
Introducing patient-reported outcomes into the VQI
Vascular specialists have long recognized that there is more to the treatment of peripheral arterial disease (PAD) than the immediate procedural success and early outcomes. The patient experience should not only be measured in clinical outcomes such as patency or…
Fighting the good fight: The case for multidisciplinary limb salvage in face of increasing diabetes, diversifying nation
Dramatic increases in rates of diabetes—particularly among Black females—through 2060 underscore the importance of a multidisciplinary team approach to limb salvage, according to Vincent Rowe, MD, professor of vascular surgery and endovascular therapy in the Keck School of Medicine at…
Fempop bypass shows reintervention benefit over endovascular therapy for advanced premature PAD
Femoropopliteal bypass is associated with decreased reinterventions at one year compared to endovascular therapy in patients with advanced premature peripheral arterial disease (PAD). This is the primary conclusion of Tanner I. Kim, MD, an integrated vascular surgery resident at Yale School…
The top 10 most popular Vascular Specialist stories in May
A pointed letter aimed at electronic health record (EHR) behemoth Epic, an argument in favor of endovascular treatment of ruptured abdominal aortic aneurysms (rAAAs) and the first-ever Corner Stitch column were among the best-read stories here on the Vascular Specialist…
Pearls of wisdom for interns
It’s June and, in less than a month, a swarm of new faces, and freshly minted MDs and DOs will descend upon most academic teaching hospitals. Many will just be getting used to being called “Dr.” They may look around…